(Q30432421)

21 June 2017

1 reference

23 October 2022

Emerging antiviral strategies to interfere with influenza virus entry (English)

1 reference

21 June 2017

Evelien Vanderlinden

1

0 references

Lieve Naesens

object named as

Lieve Naesens

series ordinal

2

0 references

publication date

25 June 2013

1 reference

PubMed ID

23801557

Medicinal Research Reviews

21 June 2017

1 March 2014

1 reference

23 October 2022

2 references

21 June 2017

23 October 2022

34

1 reference

21 June 2017

2

1 reference

21 June 2017

301-339

1 reference

Epidemiology of seasonal influenza: use of surveillance data and statistical models to estimate the burden of disease.

21 June 2017

1 reference

Towards universal influenza vaccines?

21 January 2018

1 reference

H5N1 influenza viruses: facts, not fear

21 January 2018

1 reference

1918 Influenza: the mother of all pandemics

21 January 2018

1 reference

The war against influenza: discovery and development of sialidase inhibitors

21 January 2018

1 reference

Structures of influenza A proteins and insights into antiviral drug targets.

21 January 2018

1 reference

Emerging antiviral targets for influenza A virus.

21 January 2018

1 reference

Targeting the host or the virus: current and novel concepts for antiviral approaches against influenza virus infection

21 January 2018

1 reference

Medical management of influenza infection.

21 January 2018

1 reference

Rational design of potent sialidase-based inhibitors of influenza virus replication

21 January 2018

1 reference

Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants

21 January 2018

1 reference

Global transmission of oseltamivir-resistant influenza

21 January 2018

1 reference

Fatal oseltamivir-resistant influenza virus infection

21 January 2018

1 reference

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus

21 January 2018

1 reference

Systematic review of influenza resistance to the neuraminidase inhibitors

21 January 2018

1 reference

Zanamivir pharmacokinetics and pulmonary penetration into epithelial lining fluid following intravenous or oral inhaled administration to healthy adult subjects

21 January 2018

1 reference

Evaluation of the antiviral response to zanamivir administered intravenously for treatment of critically ill patients with pandemic influenza A (H1N1) infection.

21 January 2018

1 reference

The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza

21 January 2018

1 reference

Pharmacokinetic properties of anti-influenza neuraminidase inhibitors

21 January 2018

1 reference

Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial

21 January 2018

1 reference

Effect of a single inhalation of laninamivir octanoate in children with influenza

21 January 2018

1 reference

Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition

21 January 2018

1 reference

21 January 2018

1 reference

Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity

21 January 2018

1 reference

A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.

21 January 2018

1 reference

T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro

21 January 2018

1 reference

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

21 January 2018

1 reference

Influenza hemagglutinin and neuraminidase membrane glycoproteins

21 January 2018

1 reference

A distinct lineage of influenza A virus from bats

21 January 2018

1 reference

Crystal structures of two subtype N10 neuraminidase-like proteins from bat influenza A viruses reveal a diverged putative active site

21 January 2018

1 reference

The influenza virus enigma

21 January 2018

1 reference

Assembly of influenza hemagglutinin trimers and its role in intracellular transport

21 January 2018

1 reference

Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution

21 January 2018

1 reference

Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation

21 January 2018

1 reference

Novel insights into proteolytic cleavage of influenza virus hemagglutinin

21 January 2018

1 reference

Virulence-associated sequence duplication at the hemagglutinin cleavage site of avian influenza viruses.

21 January 2018

1 reference

Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases

21 January 2018

1 reference

S acylation of the hemagglutinin of influenza viruses: mass spectrometry reveals site-specific attachment of stearic acid to a transmembrane cysteine.

21 January 2018

1 reference

Evidence for N-glycan shielding of antigenic sites during evolution of human influenza A virus hemagglutinin

21 January 2018

1 reference

Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain.

21 January 2018

1 reference

N-linked glycans direct the cotranslational folding pathway of influenza hemagglutinin.

21 January 2018

1 reference

Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence

21 January 2018

1 reference

N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication

21 January 2018

1 reference

H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes

21 January 2018

1 reference

Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion

21 January 2018

1 reference

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity

21 January 2018

1 reference

The role of receptor binding specificity in interspecies transmission of influenza viruses

21 January 2018

1 reference

A review of influenza haemagglutinin receptor binding as it relates to pandemic properties

21 January 2018

1 reference

Avian influenza A viruses differ from human viruses by recognition of sialyloligosaccharides and gangliosides and by a higher conservation of the HA receptor-binding site.

21 January 2018

1 reference

Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic

21 January 2018

1 reference

Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities.

21 January 2018

1 reference

Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic

21 January 2018

1 reference

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses

21 January 2018

1 reference

Structural basis for receptor specificity of influenza B virus hemagglutinin

21 January 2018

1 reference

Crystal structure of unliganded influenza B virus hemagglutinin

21 January 2018

1 reference

Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin

21 January 2018

1 reference

Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl

21 January 2018

1 reference

Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin

21 January 2018

1 reference

Influenza virus infection of desialylated cells.

21 January 2018

1 reference

Evolving complexities of influenza virus and its receptors

21 January 2018

1 reference

Influenza virus evolution, host adaptation, and pandemic formation

21 January 2018

1 reference

Airborne transmission of influenza A/H5N1 virus between ferrets

21 January 2018

1 reference

Influenza viruses: an introduction

21 January 2018

1 reference

Influenza virus binds its host cell using multiple dynamic interactions.

21 January 2018

1 reference

A surface plasmon resonance assay for the binding of influenza virus hemagglutinin to its sialic acid receptor

21 January 2018

1 reference

Variation and infectivity neutralization in influenza

21 January 2018

1 reference

Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?

21 January 2018

1 reference

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

21 January 2018

1 reference

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

21 January 2018

1 reference

Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody

21 January 2018

1 reference

Structure of influenza virus haemagglutinin complexed with a neutralizing antibody.

21 January 2018

1 reference

Cross-neutralization of influenza A viruses mediated by a single antibody loop

21 January 2018

1 reference

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses

21 January 2018

1 reference

Heterosubtypic antibody recognition of the influenza virus hemagglutinin receptor binding site enhanced by avidity

21 January 2018

1 reference

Human monoclonal antibodies broadly neutralizing against influenza B virus

21 January 2018

1 reference

Highly Conserved Protective Epitopes on Influenza B Viruses

21 January 2018

1 reference

A review of palivizumab and emerging therapies for respiratory syncytial virus

21 January 2018

1 reference

Nanobodies®: new ammunition to battle viruses

21 January 2018

1 reference

Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection

21 January 2018

1 reference

Introduction of N-linked glycans in the lectin domain of surfactant protein D: impact on interactions with influenza A viruses.

21 January 2018

1 reference

An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity

21 January 2018

1 reference

Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo

21 January 2018

1 reference

A Unique Sugar-binding Site Mediates the Distinct Anti-influenza Activity of Pig Surfactant Protein D

21 January 2018

1 reference

Distinctive anti-influenza properties of recombinant collectin 43.

21 January 2018

1 reference

Potential of carbohydrate-binding agents as therapeutics against enveloped viruses

21 January 2018

1 reference

Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin

21 January 2018

1 reference

Treatment of influenza A (H1N1) virus infections in mice and ferrets with cyanovirin-N.

21 January 2018

1 reference

Specific sites of N-linked glycosylation on the hemagglutinin of H1N1 subtype influenza A virus determine sensitivity to inhibitors of the innate immune system and virulence in mice

21 January 2018

1 reference

Targeting the glycans of glycoproteins: a novel paradigm for antiviral therapy

21 January 2018

1 reference

Binding affinity of GM3 lactone for influenza virus

21 January 2018

1 reference

Inhibition of influenza-virus-induced cytopathy by sialylglycoconjugates

21 January 2018

1 reference

Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains

21 January 2018

1 reference

Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus

21 January 2018

1 reference

Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy

21 January 2018

1 reference

A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin

21 January 2018

1 reference

Antiviral activity of NMSO3 against respiratory syncytial virus infection in vitro and in vivo

21 January 2018

1 reference

Intracytoplasmic trapping of influenza virus by a lipophilic derivative of aglycoristocetin.

21 January 2018

1 reference

Polysulfated sialic acid derivatives as anti-human immunodeficiency virus

21 January 2018

1 reference

Inhibition of influenza virus infections by sialylgalactose-binding peptides selected from a phage library

21 January 2018

1 reference

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

21 January 2018

1 reference

A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo

21 January 2018

1 reference

Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181.

21 January 2018

1 reference

Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection

21 January 2018

1 reference

Virus entry by endocytosis

21 January 2018

1 reference

Infectious entry pathway of influenza virus in a canine kidney cell line

21 January 2018

1 reference

Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis

21 January 2018

1 reference

Assembly of endocytic machinery around individual influenza viruses during viral entry

21 January 2018

1 reference

Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway

21 January 2018

1 reference

Influenza virus entry and infection require host cell N-linked glycoprotein

21 January 2018

1 reference

The epidermal growth factor receptor (EGFR) promotes uptake of influenza A viruses (IAV) into host cells

21 January 2018

1 reference

A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator

21 January 2018

1 reference

The broad anti-viral agent glycyrrhizin directly modulates the fluidity of plasma membrane and HIV-1 envelope

21 January 2018

1 reference

Glycyrrhizin inhibits influenza A virus uptake into the cell

21 January 2018

1 reference

Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages

21 January 2018

1 reference

A broad-spectrum antiviral targeting entry of enveloped viruses

21 January 2018

1 reference

Polycyclic peptide and glycopeptide antibiotics and their derivatives as inhibitors of HIV entry.

21 January 2018

1 reference

Anti-influenza virus activity and structure-activity relationship of aglycoristocetin derivatives with cyclobutenedione carrying hydrophobic chains.

21 January 2018

1 reference

Endocytosis of influenza viruses

21 January 2018

1 reference

Human host factors required for influenza virus replication

21 January 2018

1 reference

In vitro inhibition of human influenza A virus replication by chloroquine

21 January 2018

1 reference

Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial

21 January 2018

1 reference

Chloroquine is effective against influenza A virus in vitro but not in vivo

21 January 2018

1 reference

Fusion mutants of the influenza virus hemagglutinin glycoprotein

21 January 2018

1 reference

Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus.

21 January 2018

1 reference

Protonation of histidine and histidine-tryptophan interaction in the activation of the M2 ion channel from influenza a virus

21 January 2018

1 reference

Histidines, heart of the hydrogen ion channel from influenza A virus: toward an understanding of conductance and proton selectivity.

21 January 2018

1 reference

Influenza B virus BM2 protein has ion channel activity that conducts protons across membranes

21 January 2018

1 reference

Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel

21 January 2018

1 reference

Structural basis for the function and inhibition of an influenza virus proton channel

21 January 2018

1 reference

Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus

21 January 2018

1 reference

Structure and mechanism of the M2 proton channel of influenza A virus

21 January 2018

1 reference

The M2 proton channels of influenza A and B viruses

21 January 2018

1 reference

NMR detection of pH-dependent histidine-water proton exchange reveals the conduction mechanism of a transmembrane proton channel.

21 January 2018

1 reference

Mechanisms of proton conduction and gating in influenza M2 proton channels from solid-state NMR

21 January 2018

1 reference

Solution structure and functional analysis of the influenza B proton channel

21 January 2018

1 reference

ANTIVIRAL ACTIVITY OF 1-ADAMANTANAMINE (AMANTADINE).

21 January 2018

1 reference

Influenza virus M2 protein has ion channel activity

21 January 2018

1 reference

Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers

21 January 2018

1 reference

Computational study of drug binding to the membrane-bound tetrameric M2 peptide bundle from influenza A virus

21 January 2018

1 reference

Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro

21 January 2018

1 reference

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

21 January 2018

1 reference

Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide

21 January 2018

1 reference

Flu channel drug resistance: a tale of two sites.

21 January 2018

1 reference

Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2.

21 January 2018

1 reference

Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors

21 January 2018

1 reference

Identification of hits as matrix-2 protein inhibitors through the focused screening of a small primary amine library

21 January 2018

1 reference

Synthesis of benzopolycyclic cage amines: NMDA receptor antagonist, trypanocidal and antiviral activities.

21 January 2018

1 reference

Design and synthesis of bioactive adamantanaminoalcohols and adamantanamines

21 January 2018

1 reference

Discovery of highly potent agents against influenza A virus

21 January 2018

1 reference

Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.

21 January 2018

1 reference

Exploring the size limit of templates for inhibitors of the M2 ion channel of influenza A virus

21 January 2018

1 reference

How to overcome resistance of influenza A viruses against adamantane derivatives

21 January 2018

1 reference

Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion

21 January 2018

1 reference

A spring-loaded mechanism for the conformational change of influenza hemagglutinin

21 January 2018

1 reference

Structure of influenza haemagglutinin at the pH of membrane fusion

21 January 2018

1 reference

Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion

21 January 2018

1 reference

Composition and functions of the influenza fusion peptide

21 January 2018

1 reference

Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones

21 January 2018

1 reference

Novel inhibitors of influenza virus fusion: structure-activity relationship and interaction with the viral hemagglutinin

21 January 2018

1 reference

Inhibition of influenza A virus (H1N1) fusion by benzenesulfonamide derivatives targeting viral hemagglutinin

21 January 2018

1 reference

Identification of a novel HA conformational change inhibitor of human influenza virus

21 January 2018

1 reference

An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology

21 January 2018

1 reference

Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins

21 January 2018

1 reference

Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus

21 January 2018

1 reference

Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro

21 January 2018

1 reference

Dextran sulfate inhibits the fusion of influenza virus with model membranes, and suppresses influenza virus replication in vivo

21 January 2018

1 reference

Dextran sulfate inhibits fusion of influenza virus and cells expressing influenza hemagglutinin with red blood cells

21 January 2018

1 reference

In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.

21 January 2018

1 reference

Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry

21 January 2018

1 reference

Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro

21 January 2018

1 reference

Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1.

21 January 2018

1 reference

Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins

21 January 2018

1 reference

Mammalian defensins in the antimicrobial immune response

21 January 2018

1 reference

Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol

21 January 2018

1 reference

Characteristics of arbidol-resistant mutants of influenza virus: implications for the mechanism of anti-influenza action of arbidol

21 January 2018

1 reference

Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

21 January 2018

1 reference

Membranotropic effects of arbidol, a broad anti-viral molecule, on phospholipid model membranes

21 January 2018

1 reference

Pharmacokinetic properties and bioequivalence of two formulations of arbidol: an open-label, single-dose, randomized-sequence, two-period crossover study in healthy Chinese male volunteers

21 January 2018

1 reference

Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection.

21 January 2018

1 reference

A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza

21 January 2018

1 reference

Antibody recognition of a highly conserved influenza virus epitope

21 January 2018

1 reference

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

21 January 2018

1 reference

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

21 January 2018

1 reference

A highly conserved neutralizing epitope on group 2 influenza A viruses

21 January 2018

1 reference

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

21 January 2018

1 reference

A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes

21 January 2018

1 reference

Structural basis of influenza virus neutralization

21 January 2018

1 reference

Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin

21 January 2018

1 reference

Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket

21 January 2018

1 reference

Nuclear import of the influenza A virus transcriptional machinery.

21 January 2018

1 reference

Identification of the domains of the influenza A virus M1 matrix protein required for NP binding, oligomerization and incorporation into virions

21 January 2018

1 reference

The role of nuclear import and export in influenza virus infection

21 January 2018

1 reference

Influenza virus assembly and budding

21 January 2018

1 reference

Unpacking the incoming influenza virus

21 January 2018

1 reference

Dissection of influenza A virus M1 protein: pH-dependent oligomerization of N-terminal domain and dimerization of C-terminal domain

21 January 2018

1 reference

Structural changes in Influenza virus at low pH characterized by cryo-electron tomography

21 January 2018

1 reference

Influenza virus uncoating in infected cells and effect of rimantadine

21 January 2018

1 reference

A small percentage of influenza virus M1 protein contains zinc but zinc does not influence in vitro M1-RNA interaction

21 January 2018

1 reference

Architecture of ribonucleoprotein complexes in influenza A virus particles

21 January 2018

1 reference

The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA

21 January 2018

1 reference

An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein

21 January 2018

1 reference

Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import

21 January 2018

1 reference

Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus

21 January 2018

1 reference

The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication.

21 January 2018

1 reference

Activity of Ingavirin (6-[2-(1H-Imidazol-4-yl)ethylamino]-5-oxo-hexanoic Acid) Against Human Respiratory Viruses in in Vivo Experiments

21 January 2018

1 reference

Identification of influenza A nucleoprotein as an antiviral target

21 January 2018

1 reference

Design, synthesis, and in vitro biological evaluation of 1H-1,2,3-triazole-4-carboxamide derivatives as new anti-influenza A agents targeting virus nucleoprotein

21 January 2018

1 reference

High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity

21 January 2018

1 reference

Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers

21 January 2018

1 reference

Cellular networks involved in the influenza virus life cycle

21 January 2018

1 reference

The host interactome of influenza virus presents new potential targets for antiviral drugs

21 January 2018

1 reference

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

21 January 2018

1 reference

Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor

21 January 2018

1 reference

Role of protein kinase C betaII in influenza virus entry via late endosomes

21 January 2018

1 reference

Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence

21 January 2018

1 reference

Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses

21 January 2018

1 reference

Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production

21 January 2018

1 reference

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry

21 January 2018

1 reference

Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion

21 January 2018

1 reference

Hospitalization Attributable to Influenza and Other Viral Respiratory Illnesses in Canadian Children

21 January 2018

1 reference

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

21 January 2018

1 reference

Fusion and infection of influenza and Sendai viruses as modulated by dextran sulfate: a comparative study

21 January 2018

1 reference

12 December 2020

Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells

1 reference

12 December 2020

Antiviral activity of influenza virus M1 zinc finger peptides

1 reference

12 December 2020

Transport of incoming influenza virus nucleocapsids into the nucleus

1 reference

12 December 2020

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

1 reference

12 December 2020

An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus.

1 reference

12 December 2020

Glycosylation requirements for intracellular transport and function of the hemagglutinin of influenza virus

1 reference

12 December 2020

Epidemiology of influenza

1 reference

12 December 2020

Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety

1 reference

12 December 2020

The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C

1 reference

12 December 2020

Glycyrrhizic acid inhibits influenza virus growth in embryonated eggs

1 reference

12 December 2020

Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease

1 reference

12 December 2020

The interaction of wheat germ agglutinin with sialoglycoproteins. The role of sialic acid

1 reference

12 December 2020

Infectious cell entry mechanism of influenza virus.

1 reference

12 December 2020

A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains.

1 reference

12 December 2020

Protection against the mouse-adapted A/FM/1/47 strain of influenza A virus in mice by a monoclonal antibody with cross-neutralizing activity among H1 and H2 strains.

1 reference

12 December 2020

pH-dependent changes in photoaffinity labeling patterns of the H1 influenza virus hemagglutinin by using an inhibitor of viral fusion.

1 reference

12 December 2020

Expanding the armamentarium against respiratory viral infections: DAS181

1 reference

12 December 2020

[Effect of the antiviral drug Ingaviruin on intracellular transformations and import into the nucleus of influenza A virus nucleocapsid protein]

1 reference

12 December 2020

Inhibition of influenza A virus replication by compounds interfering with the fusogenic function of the viral hemagglutinin

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

New antiviral antibiotics, kistamicins A and B. I. Taxonomy, production, isolation, physico-chemical properties and biological activities.

1 reference

12 December 2020

Ultrastructural analysis of the nuclear localization sequences on influenza A ribonucleoprotein complexes

1 reference

12 December 2020

Oligosaccharides in the stem region maintain the influenza virus hemagglutinin in the metastable form required for fusion activity.

1 reference

12 December 2020

Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins

1 reference

12 December 2020

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

1 reference

12 December 2020

On the mechanism underlying initiation of influenza virus infection

1 reference

12 December 2020

Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity

1 reference

12 December 2020

Identifiers

DOI

10.1002/MED.21289

1 reference

21 June 2017

0 references

1 reference

PubMed ID

23801557